Neisserial Porins and Antigen Presenting Cells

奈瑟氏球菌孔蛋白和抗原呈递细胞

基本信息

  • 批准号:
    6737448
  • 负责人:
  • 金额:
    $ 41.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-04-01 至 2006-03-31
  • 项目状态:
    已结题

项目摘要

Neisserial porins (gonococcal Protein I [PIA or PIB] or meningococcal class 1 [PorA], 2 or 3 [PorB] proteins) are the major protein constituent of the Neisserial outer membrane. They have significant homology in structure and function amongst themselves and other Gram-negative porins. We have previously demonstrated that the Neisserial porins activate B lymphocytes, increasing the surface expression of the costimulatory ligand B7- 2, which improves the B cell's ability to "costimulate" T lymphocytes. The induction of B7-2 expression is directly related to the porins' adjuvant ability. As Neisserial porins are molecules that maintain a common "pattern" present on Gram- negative organisms, it is probable that the activation of antigen presenting cells (APC), including B cells and dendritic cells, is through pattern recognition receptors. A family of these receptors has recently been described by which a number of conserved bacterial products including LPS, bacterial lipopeptides, peptidoglycan, etc., can mediate cell activation and induction of costimulatory molecules. These have been termed Toll-like receptors (TLR) because of their significant homology to receptors present in Drosophila that are important for innate immunity. The TLR family of receptors have also been shown to be the main mediators of innate immune responses that have previously been described for these microbial products. We have preliminary data demonstrating that B cell activation by Neisserial porins is mediated through signaling by one of these TLRs, namely TLR2. The overriding hypothesis of this proposal is that the immune stimulatory effect of Neisserial porins and, therefore, their adjuvant activity, is due to an interaction of the porins with TLR2 on antigen presenting cells (especially B cells and dendritic cells) and this event initiates a set of common signal transduction events that induces cell activation and increases B7-2 and class II MHC surface expression. The following aims of the proposal will attempt to prove this hypothesis: 1) investigate the interaction of Neisserial porin with TLR2 and demonstrate the importance of TLR2 mediated signaling in their adjuvant activity, 2) explore the significance of signal transduction events induced in B cells and dendritic cells (including NF-kappaB activation protein tyrosine kinase activation and MAPKK activation) by Neisserial porins in relationship to their adjuvant activity and whether these events are due to immune cell stimulation through TLR2, and 3) determine whether dendritic cell activation by the Neisserial porins is mediated through TLR2 and if their ability to activate dendritic cells is related to the their immunopotentiating activity.
奈瑟氏菌(淋球菌蛋白I [PIA或PIB]或脑膜炎球菌1 [pora],2或3 [PORB]蛋白)是奈瑟氏外膜的主要蛋白质成分。 它们在彼此之间以及其他革兰氏阴性波的结构和功能方面具有重要的同源性。 我们以前已经证明,奈瑟氏菌孔蛋白激活B淋巴细胞,增加了凸出配体B7-2的表面表达,从而提高了B细胞“ costaute” T淋巴细胞的能力。 B7-2表达的诱导与孔蛋白的辅助能力直接相关。 由于静脉孔蛋白是在革兰氏阴性生物上保持常见“模式”的分子,因此抗原呈递细胞的激活(包括B细胞和树突状细胞)很可能通过模式识别受体。最近已经描述了这些受体的家族,其中许多保守的细菌产物,包括LPS,细菌脂肽,肽聚糖等,可以介导细胞激活和诱导共刺激分子。 这些被称为Toll样受体(TLR),因为它们与果蝇中存在的受体具有重要同源性,对先天免疫很重要。 TLR的受体家族也已被证明是先前用于这些微生物产物的先天免疫反应的主要介体。 我们的初步数据表明,奈瑟氏孔蛋白的B细胞激活是通过这些TLR之一(即TLR2)信号传导介导的。 The overriding hypothesis of this proposal is that the immune stimulatory effect of Neisserial porins and, therefore, their adjuvant activity, is due to an interaction of the porins with TLR2 on antigen presenting cells (especially B cells and dendritic cells) and this event initiates a set of common signal transduction events that induces cell activation and increases B7-2 and class II MHC surface expression. The following aims of the proposal will attempt to prove this hypothesis: 1) investigate the interaction of Neisserial porin with TLR2 and demonstrate the importance of TLR2 mediated signaling in their adjuvant activity, 2) explore the significance of signal transduction events induced in B cells and dendritic cells (including NF-kappaB activation protein tyrosine kinase activation and MAPKK activation) by Neisserial porins in relationship对于它们的辅助活性以及这些事件是否是由于通过TLR2刺激的免疫细胞刺激,以及3)确定奈瑟氏骨porins的树突状细胞激活是否通过TLR2介导,以及它们激活树突状细胞的能力是否与其免疫肠肠性活性有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LEE Mark WETZLER其他文献

LEE Mark WETZLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LEE Mark WETZLER', 18)}}的其他基金

Gonococcal Vaccine Evaluation in a Humanized Mouse Model
人源化小鼠模型中的淋球菌疫苗评估
  • 批准号:
    9389653
  • 财政年份:
    2013
  • 资助金额:
    $ 41.71万
  • 项目类别:
Gonococcal Vaccine Evaluation in a Humanized Mouse Model
人源化小鼠模型中的淋球菌疫苗评估
  • 批准号:
    8584887
  • 财政年份:
    2013
  • 资助金额:
    $ 41.71万
  • 项目类别:
Gonococcal Vaccine Evaluation in a Humanized Mouse Model
人源化小鼠模型中的淋球菌疫苗评估
  • 批准号:
    8868920
  • 财政年份:
    2013
  • 资助金额:
    $ 41.71万
  • 项目类别:
Gonococcal Vaccine Evaluation in a Humanized Mouse Model
人源化小鼠模型中的淋球菌疫苗评估
  • 批准号:
    8702079
  • 财政年份:
    2013
  • 资助金额:
    $ 41.71万
  • 项目类别:
Boston University Inflammatory Disorders Training Grant
波士顿大学炎症性疾病培训补助金
  • 批准号:
    8860100
  • 财政年份:
    2011
  • 资助金额:
    $ 41.71万
  • 项目类别:
Animal Core
动物核心
  • 批准号:
    7790043
  • 财政年份:
    2010
  • 资助金额:
    $ 41.71万
  • 项目类别:
Effect of Neisserial Porin in Immune Cell Apoptosis
奈瑟氏球菌孔蛋白对免疫细胞凋亡的影响
  • 批准号:
    6758513
  • 财政年份:
    2002
  • 资助金额:
    $ 41.71万
  • 项目类别:
Effect of Neisserial Porin in Immune Cell Apoptosis
奈瑟氏球菌孔蛋白对免疫细胞凋亡的影响
  • 批准号:
    6913540
  • 财政年份:
    2002
  • 资助金额:
    $ 41.71万
  • 项目类别:
Effect of Neisserial Porin in Immune Cell Apoptosis
奈瑟氏球菌孔蛋白对免疫细胞凋亡的影响
  • 批准号:
    6544274
  • 财政年份:
    2002
  • 资助金额:
    $ 41.71万
  • 项目类别:
Effect of Neisserial Porin in Immune Cell Apoptosis
奈瑟氏球菌孔蛋白对免疫细胞凋亡的影响
  • 批准号:
    6645684
  • 财政年份:
    2002
  • 资助金额:
    $ 41.71万
  • 项目类别:

相似海外基金

Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
4C-MenB 免疫预防实验性尿道淋病奈瑟菌感染的功效。
  • 批准号:
    10615898
  • 财政年份:
    2021
  • 资助金额:
    $ 41.71万
  • 项目类别:
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
4C-MenB 免疫预防实验性尿道淋病奈瑟菌感染的功效。
  • 批准号:
    10263478
  • 财政年份:
    2021
  • 资助金额:
    $ 41.71万
  • 项目类别:
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
4C-MenB 免疫预防实验性尿道淋病奈瑟菌感染的功效。
  • 批准号:
    10435532
  • 财政年份:
    2021
  • 资助金额:
    $ 41.71万
  • 项目类别:
Identification of Immunologic Mechanisms of Enhanced Ng Clearance Induced by Nm OMV-based Vaccines
Nm OMV 疫苗诱导 Ng 清除增强的免疫机制鉴定
  • 批准号:
    10588241
  • 财政年份:
    2019
  • 资助金额:
    $ 41.71万
  • 项目类别:
Identification of Immunologic Mechanisms of Enhanced Ng Clearance Induced by Nm OMV-based Vaccines
Nm OMV 疫苗诱导 Ng 清除增强的免疫机制鉴定
  • 批准号:
    10362594
  • 财政年份:
    2019
  • 资助金额:
    $ 41.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了